Sandoz

About Sandoz

Sandoz is a global pharmaceutical manufacturer focused on generic medicines and biosimilars. The company is a leading producer of anti-infectives—particularly penicillins—and supplies active pharmaceutical ingredients (APIs) and finished-dose formulations to healthcare systems worldwide. Its operations span chemical synthesis, industrial fermentation, and biopharmaceutical manufacturing, with a strong presence in Europe.

Sandoz maintains a vertically integrated penicillin network in Europe and invests in advanced capabilities for biosimilar development and analytical characterization. Key sites include antibiotics production in Kundl, Austria; biosimilar R&D in Holzkirchen, Germany; and expanding biologics and bioproduction activities in Slovenia. The company emphasizes secure, regional supply chains for critical medicines and manufactures to international GMP and quality standards, making it a significant player at the intersection of the chemical and life sciences industries.

Official website: sandoz.com

Projects Sandoz is involved in chemXplore Alpha

chemXplore tracks active investment projects involving Sandoz, across sectors such as Basic Chemicals, Biobased & Circular, and Polymers.

Sandoz's role is mapped on each — as Owner, Operator, and Developer.

Sandoz Lendava Production plant for biosimilar medicines · Slovenia
Owner
Under Construction
2023-03
2023
2026
Sandoz Targu Mures antibiotic generics expansion · Romania
Owner · Operator
Under Construction
2004-01